Axepta
Designed to support cognitive focus to manage hyperactivity and alleviate behavioural distractions.
- Categories
- Mental Health · Adhd & Focus
- Active ingredient
- Atomoxetine
- Route
- Oral use
- Form
- Tablet
- Strengths
- 10mg · 18mg · 25mg · 40mg
Prescription and consultation requirements for Axepta vary by destination and are determined by the fulfilment partner.
Axepta details
- Alternative names
- atomoxetine
- Therapeutic class
- Selective Norepinephrine Reuptake Inhibitor (SNRI)
- Pharmacological class
- Non-Stimulant ADHD Agent
- Known off-label uses
- narcolepsy
- Contraindications
- narrow-angle glaucoma; pheochromocytoma; MAO inhibitor therapy
- Minor side effects
- nausea; decreased appetite; somnolence
- Moderate side effects
- dry mouth; erectile dysfunction; insomnia
- Dosage forms
- Tablet
- Administration route
- Oral use
- Supply category
- Prescription-only medicine (POM)
- Manufacturer
- Torrent Pharmaceuticals Ltd
- Onset Time
- 2–4 weeks
- Duration
- 12–24 hours
- Storage instructions
- Store below 25°C.
- Drug interactions
- MAO Inhibitors; Fluoxetine; Paroxetine
- Age restrictions
- Approved for children over six years, adolescents, and adults.
- Pregnancy and breastfeeding
- TGA Category C: Use if clinically needed. Breastfeeding: Consult a doctor.
Serious side effects
suicidal ideation, requires immediate medical attention; severe hepatotoxicity, requires immediate medical attention
Patient summary
designed to support cognitive focus to manage hyperactivity and alleviate behavioural distractions.
Mechanism of action
Selectively inhibits the presynaptic norepinephrine transporter, elevating extracellular transmitter levels in the prefrontal cortex.